Current Clinical Trial Studies

We are currently offering clinical trials in the areas shown below. For more information, just click on the name of the study. All of our clinical trials follow FDA guidelines and adhere to the standards of good clinical practice. Leading national and international medical companies serve as sponsors for all of our trials. If you decide to take part in one of our studies, you can be assured that you will receive excellent care. That is our promise to you.


Chronic Obstructive Pulmonary Disease (COPD)
Start Date: 5/1/2015
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
A 52 week, randomized, double-blind study to assess the efficacy and safety of PT010 relative to PT003 and PT009 on COPD exacerbations.

Disease Targeted:
Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Objectives:
To compare the efficacy and safety of 3 different inhaled medications on order to see which group of patients have fewer exacerbations and more improvement in lung function tests.


Chronic Low Back Pain
Start Date: 2/1/2017
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
A randomized, double-blind, placebo controlled clinical trail of structured opioid discontinuation versus continued opioid therapy in suboptimal and optimal responders to high-dose, long-term opioid analgesic therapy for chronic pain.

Disease Targeted:
Chronic Low Back Pain

Objectives:
Pre-qualification requires current treatment for chronic low back pain with either Morphine Sulfate ER, Oxycodone ER or Oxymorphone ER. Participants must be currently taking one of the above medications twice daily for at least 3 months prior to study entry.


Adolescent Constipation
Start Date: 5/29/2017
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
A 14 week study on the effectiveness of plecanatide for children aged 12 to 17 years old with a diagnosis of constipation.

Disease Targeted:
Chronic Constipation in Children

Objectives:
To evaluate the safety and effectiveness of plecanatide for the treatment of chronic constipation in adolescent patients.


Diabetic Gastroparesis
Start Date: 10/1/2017
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
A 22 week, double blind, randomized study on the safety and efficacy of Relamorelin for the treatment of gastroparesis in patients with Type I or Type II Diabetes.

Disease Targeted:
Diabetic Gastroparesis

Objectives:
To evaluate the safety and efficacy of Relamorelin in patients with diabetic gastroparesis.


Hypertension
Start Date: 10/1/2017
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
A 38 week study the effectiveness of bexagliflozin (currently used to treat diabetes) on patients with high blood pressure.

Disease Targeted:
Hypertension

Objectives:
To evaluate the efficacy and safety of bexagliflozin in patients with hypertension that is not adequately controlled by standard of care.


Type II Diabetes
Start Date: 10/1/2017
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
A 29 week study on the effectiveness of bexagliflozin for subjects taking metformin.

Disease Targeted:
Type II Diabetes

Objectives:
To evaluate the efficacy and safety of bexagliflozin in subjects with Type II Diabetes who are not adequately controlled by metformin alone.